<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37333646</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>1196721</StartPage><MedlinePgn>1196721</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1196721</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1196721</ELocationID><Abstract><AbstractText>The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19 (PASC) is not well explored, although a growing population of convalescent COVID-19 patients with manifestation of PASC is observed. We analyzed the SARS-CoV-2-specific immune response, via pseudovirus neutralizing assay and multiparametric flow cytometry in 40 post-acute sequelae of COVID-19 patients with non-specific PASC manifestation and 15 COVID-19 convalescent healthy donors. Although frequencies of SARS-CoV-2-reactive CD4+ T cells were similar between the studied cohorts, a stronger SARS-CoV-2 reactive CD8+ T cell response, characterized by IFN<i>&#x3b3;</i> production and predominant T<sub>EMRA</sub> phenotype but low functional TCR avidity was detected in PASC patients compared to controls. Of interest, high avidity SARS-CoV-2-reactive CD4+ and CD8+ T cells were comparable between the groups demonstrating sufficient cellular antiviral response in PASC. In line with the cellular immunity, neutralizing capacity in PASC patients was not inferior compared to controls. In conclusion, our data suggest that PASC may be driven by an inflammatory response triggered by an expanded population of low avidity SARS-CoV-2 reactive pro-inflammatory CD8+ T cells. These pro-inflammatory T cells with TEMRA phenotype are known to be activated by a low or even without TCR stimulation and lead to a tissue damage. Further studies including animal models are required for a better understanding of underlying immunopathogensis. Summary: A CD8+ driven persistent inflammatory response triggered by SARS-CoV-2 may be responsible for the observed sequelae in PASC patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Paniskaki, Konik, Anft, Heidecke, Meister, Pfaender, Krawczyk, Zettler, J&#xe4;ger, Gaeckler, Dolff, Westhoff, Rohn, Stervbo, Scheibenbogen, Witzke and Babel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paniskaki</LastName><ForeName>Krystallenia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konik</LastName><ForeName>Margarethe J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anft</LastName><ForeName>Moritz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidecke</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CellTrend GmbH, Luckenwalde, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meister</LastName><ForeName>Toni L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaender</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krawczyk</LastName><ForeName>Adalbert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zettler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xe4;ger</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaeckler</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolff</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westhoff</LastName><ForeName>Timm H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohn</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stervbo</LastName><ForeName>Ulrik</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheibenbogen</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Immunology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Campus Virchow, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzke</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babel</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - University Clinic Berlin, BIH Center for Regenerative Therapies (BCRT) Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BMI</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Author HH was employed by company CellTrend GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37333646</ArticleId><ArticleId IdType="pmc">PMC10272838</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1196721</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adamo S., Michler J., Zurbuchen Y., Cervia C., Taeschler P., Raeber M. E., et al. . (2022). Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature 602, 148&#x2013;155. doi: 10.1038/s41586-021-04280-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04280-x</ArticleId><ArticleId IdType="pmc">PMC8810382</ArticleId><ArticleId IdType="pubmed">34875673</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A., Bena J., Pantalone K. M., Burguera B. (2021). Association of obesity with postacute sequelae of COVID-19. Diabetes Obes. Metab. 23, 2183&#x2013;2188. doi: 10.1111/dom.14454</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14454</ArticleId><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Anft M., Paniskaki K., Blazquez-Navarro A., Doevelaar A., Seibert F. S., H&#xf6;lzer B., et al. . (2020). COVID-19-induced ARDS is associated with decreased frequency of activated memory/effector T cells expressing CD11a++. Mol. Ther. 28, 2691&#x2013;2702. doi: 10.1016/j.ymthe.2020.10.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7543694</ArticleId><ArticleId IdType="pubmed">33186542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacher P., Rosati E., Esser D., Martini G. R., Saggau C., Schiminsky E., et al. . (2020). Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53, 1258&#x2013;1271e5. doi: 10.1016/j.immuni.2020.11.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.016</ArticleId><ArticleId IdType="pmc">PMC7689350</ArticleId><ArticleId IdType="pubmed">33296686</ArticleId></ArticleIdList></Reference><Reference><Citation>Balinas C., Cabanas H., Staines D., Marshall-Gradisnik S. (2019). Transient receptor potential melastatin 2 channels are overexpressed in Myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 17:401. doi: 10.1186/s12967-019-02155-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02155-4</ArticleId><ArticleId IdType="pmc">PMC6891975</ArticleId><ArticleId IdType="pubmed">31796045</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F., Palladini M., Paolini M., Melloni E., Vai B., de Lorenzo R., et al. . (2021). Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behav. Immun. Health 18:100387. doi: 10.1016/j.bbih.2021.100387, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste O., Allenbach Y. (2019). Inclusion body myositis: accumulation of evidence for its autoimmune origin. Brain 142, 2549&#x2013;2551. doi: 10.1093/brain/awz229, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz229</ArticleId><ArticleId IdType="pubmed">31497859</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., Br&#xfc;ck W. (2000). Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 123, 1174&#x2013;1183. doi: 10.1093/brain/123.6.1174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.6.1174</ArticleId><ArticleId IdType="pubmed">10825356</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., O&#x2019;Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., et al. . (2022). Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 28, 879&#x2013;882. doi: 10.1038/s41591-022-01766-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B. M., van de Sande M. I., de Meirleir K. L., Klimas N. G., Broderick G., Mitchell T., et al. . (2011). Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 270, 327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon I. S., Li C., Son Y. M., Goplen N. P., Wu Y., Cassmann T., et al. . (2021). Immune signatures underlying post-acute COVID-19 lung sequelae. Sci. Immunol. 6:eabk1741. doi: 10.1126/sciimmunol.abk1741, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan M. J., Mateus J., Kato Y., Hastie K. M., Dawen Yu E., Faliti C. E., et al. . (2021). Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371:eabf4063. doi: 10.1126/science.abf4063, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Reem Y., et al. . (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. ECinicalMedinice. 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>DiCarlo A. L., Fuldner R., Kaminski J., Hodes R. (2009). Aging in the context of immunological architecture, function and disease outcomes. Trends Immunol. 30, 293&#x2013;294. doi: 10.1016/j.it.2009.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.05.003</ArticleId><ArticleId IdType="pubmed">19541534</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R. A., McAuley H., Harrison E. M., Shikotra A., Singapuri A., Sereno M., et al. . (2021). Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med. 9, 1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay J. B., Brann D. H., Hachem R. A., Jang D. W., Oliva A. D., Ko T., et al. . (2022). Persistent post&#x2013;COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci. Transl. Med. 14:eadd04. doi: 10.1126/scitranslmed.add0484</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.add0484</ArticleId><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., et al. . (2021). Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 19, 2546&#x2013;2553. doi: 10.1111/jth.15490, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese M. A., Fugger L. (2009). Pathogenic CD8+ T cells in multiple sclerosis. Ann. Neurol. 66, 132&#x2013;141. doi: 10.1002/ana.21744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21744</ArticleId><ArticleId IdType="pubmed">19743458</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Dupuis G., le Page A., Frost E. H., Cohen A. A., et al. . (2018). Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front. Immunol. 8:1960. doi: 10.3389/fimmu.2017.01960, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01960</ArticleId><ArticleId IdType="pmc">PMC5767595</ArticleId><ArticleId IdType="pubmed">29375577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore W., Lund B. T., Li P., Levy M. A., Kelland E. E., Akbari O., et al. . (2020). Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsingremitting multiple sclerosis. J. Neuroinflammation 17:189. doi: 10.1186/s12974-020-01847-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01847-9</ArticleId><ArticleId IdType="pmc">PMC7296935</ArticleId><ArticleId IdType="pubmed">32539719</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J. M., Levings M. K. (2013). Immune regulation in obesity-associated adipose inflammation. J. Immunol. 191, 527&#x2013;532. doi: 10.4049/jimmunol.1301035</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301035</ArticleId><ArticleId IdType="pubmed">23825387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson B. A., Visvabharathy L., Ali S. T., Kang A. K., Patel T. R., Clark J. R., et al. . (2022). Plasma biomarkers of neuropathogenesis in hospitalized patients with covid-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm 9:e1151. doi: 10.1212/nxi.0000000000001151, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J. H., Rha M. S., Sa M., Choi K. H., Jeon H. J., Seok H., et al. . (2021). SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat. Commun. 12:4043. doi: 10.1038/s41467-021-24377-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24377-1</ArticleId><ArticleId IdType="pmc">PMC8245549</ArticleId><ArticleId IdType="pubmed">34193870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S. J., Khoury D. S., Reynaldi A., Juno J. A., Wheatley A. K., Stadler A., et al. . (2022). Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? Nat. Rev. Immunol. 22, 387&#x2013;397. doi: 10.1038/s41577-022-00716-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00716-1</ArticleId><ArticleId IdType="pmc">PMC9047577</ArticleId><ArticleId IdType="pubmed">35484322</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Bateman L. (2021). Will COVID-19 lead to Myalgic encephalomyelitis/chronic fatigue syndrome? Front. Med. 7:1132. doi: 10.3389/fmed.2020.606824, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabee C. M., Neely O. C., Domingos A. I. (2020). Obesity: a neuroimmunometabolic perspective. Nat. Rev. Endocrinol. 16, 30&#x2013;43. doi: 10.1038/s41574-019-0283-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0283-6</ArticleId><ArticleId IdType="pubmed">31776456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind L., Svensson A., Thrn K., Krzyzowska M., Eriksson K. (2021). CD8+ T cells in the central nervous system of mice with herpes simplex infection are highly activated and express high levels of CCR5 and CXCR3. J. Neurovirol. 27, 145&#x2013;153. doi: 10.1007/s13365-020-00940-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00940-2</ArticleId><ArticleId IdType="pmc">PMC7831625</ArticleId><ArticleId IdType="pubmed">33492607</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K. M., Watson R. O., Schneider J. M., Neff P. M., Yamada E., Zhang M., et al. . (2022). SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18:e1010359. doi: 10.1371/journal.ppat.1010359, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Nikolajczyk B. S. (2019). Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front. Immunol. 10:1587. doi: 10.3389/fimmu.2019.01587, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01587</ArticleId><ArticleId IdType="pmc">PMC6653202</ArticleId><ArticleId IdType="pubmed">31379820</ArticleId></ArticleIdList></Reference><Reference><Citation>Loyal L., Braun J., Henze L., Kruse B., Dingeldey M., Reimer U., et al. . (2021). Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science 374:eabh1823. doi: 10.1126/science.abh1823, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh1823</ArticleId><ArticleId IdType="pmc">PMC10026850</ArticleId><ArticleId IdType="pubmed">34465633</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M. G., de Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., et al. . (2020). Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 89, 594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M. G., Palladini M., de Lorenzo R., Magnaghi C., Poletti S., Furlan R., et al. . (2021). Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 94, 138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Bunker C. B., Ciurtin C., Porter J. C., Chambers C. R., Papdopoulou C., et al. . (2021). Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect. Dis. 21:912. doi: 10.1016/s1473-3099(21)00133-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00133-x</ArticleId><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens S. J., et al. . (2021). Post-acute COVID-19 syndrome. Nat. Med. 27, 601&#x2013;615. doi: 10.1038/s41591-021-01283-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Northfield J. W., Loo C. P., Barbour J. D., Spotts G., Hecht F. M., Klenerman P., et al. . (2007). Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ TEMRA cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J. Virol. 81, 5759&#x2013;5765. doi: 10.1016/j.xcrm.2020.100081, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100081</ArticleId><ArticleId IdType="pmc">PMC1900265</ArticleId><ArticleId IdType="pubmed">17376902</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neal A., Hanson M. (2021). The enterovirus theory of disease etiology in Myalgic encephalomyelitis/chronic fatigue syndrome: a critical review. Front. Med. (Lausanne) 8:908. doi: 10.3389/fmed.2021.688486, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.688486</ArticleId><ArticleId IdType="pmc">PMC8253308</ArticleId><ArticleId IdType="pubmed">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniskaki K., Anft M., Meister T. L., Marheinecke C., Pfaender S., Skrzypczyk S., et al. . (2022). Immune response in moderate to critical breakthrough COVID-19 infection after mRNA vaccination. Front. Immunol. 13:816220. doi: 10.3389/fimmu.2022.816220, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.816220</ArticleId><ArticleId IdType="pmc">PMC8821964</ArticleId><ArticleId IdType="pubmed">35145522</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Deeks S. G. (2022). Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 43, 268&#x2013;270. doi: 10.1016/j.it.2022.02.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C. M. L., Patel S. K., et al. . (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216. doi: 10.1038/s41590-021-01113-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A. D., Van Elzakker M. B. (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12:698169. doi: 10.3389/fmicb.2021.698169, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinke S., Geissler S., Taylor W., Schmidt-Bleek K., Juelke K., Schwachmeyer V., et al. . (2013). Terminally differentiated CD8+ T cells negatively affect bone regeneration in humans. Sci. Transl. Medic. 5:177ra36. doi: 10.1126/scitranslmed.3004754, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004754</ArticleId><ArticleId IdType="pubmed">23515078</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer P. E., Kirwan J. P., Rosen C. J. (2022). Post-acute sequelae of COVID-19: a metabolic perspective. elife 11:e78200. doi: 10.7554/eLife.78200</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., et al. . (2021). Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin. Infect. Dis. 74, 1191&#x2013;1198. doi: 10.1093/cid/ciab611, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sell H., Habich C., Eckel J. (2012). Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8, 709&#x2013;716. doi: 10.1038/nrendo.2012.114</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.114</ArticleId><ArticleId IdType="pubmed">22847239</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D. G., Ng R. H., Wang K., Choi J., et al. . (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cells 185, 881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X. G., Li J. Z., Alter G., et al. . (2023). Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 76, e487&#x2013;e490. doi: 10.1093/cid/ciac722, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., et al. . (2022). Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1284437 patients. Lancet Psychiatry 9, 815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilg H., Moschen A. R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772&#x2013;783. doi: 10.1038/nri1937</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1937</ArticleId><ArticleId IdType="pubmed">16998510</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y., Zhang Y., Li Y., Zhao Q., Bi Y., Lu X., et al. . (2021). Post-traumatic stress symptoms in COVID-19 survivors: a self-report and brain imaging follow-up study. Mol. Psychiatry 26, 7475&#x2013;7480. doi: 10.1038/s41380-021-01223-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01223-w</ArticleId><ArticleId IdType="pmc">PMC8290134</ArticleId><ArticleId IdType="pubmed">34285348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B., Boustani K., Ogger P. P., Papadaki A., Tonkin J., Orton C. M., et al. . (2022). Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 55, 542&#x2013;556.e5. doi: 10.1016/j.immuni.2022.01.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V. A., Xie R., et al. . (2022). Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front. Cell. Infect. Microbiol. 12:861703. doi: 10.3389/fcimb.2022.861703, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong H., Cui M., Kong N., Jing N., Xu Y., Liu X., et al. . (2023). Cytotoxic CD161&#x2212;CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. EBioMedicine 90:104507. doi: 10.1016/j.ebiom.2023.104507, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104507</ArticleId><ArticleId IdType="pmc">PMC10011749</ArticleId><ArticleId IdType="pubmed">36893588</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L., Jing S., Zhang K., Milne R., Wang H. (2022). Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Int. J. Infect. Dis. 121, 195&#x2013;202. doi: 10.1016/j.ijid.2022.05.031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.05.031</ArticleId><ArticleId IdType="pmc">PMC9107628</ArticleId><ArticleId IdType="pubmed">35584743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>